anti-spike antibody – Page 3 – Communicable Diseases Research

Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants

Article

Published on 2022-08-312022-11-15
Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술,

Affinity of anti-spike antibodies to three major SARS-CoV-2 variants in recipients of three major vaccines

Research

Published on 2022-08-252022-10-05
Journal: Communications Medicine [Category] 진단,

Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study

코로나 바이러스 질병 2019(COVID-19) 도쿄의 위탁 병원에서 의료 종사자 사이의 획기적인 감염 및 백신 접종 후 중화 항체: 사례-대조군 일치 연구

Article

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 진단,

[키워드] Alpha Alpha variant anti-spike antibodies anti-spike antibody Antibody titers Asymptomatic B.1.1.7 B.1.617.2 BNT162b2 Breakthrough infection Cohort Control controls coronavirus disease Coronavirus disease 2019 Coverage COVID-19 COVID-19 case COVID-19 cases Delta delta variant effective vaccine Effective vaccines Epidemic epidemic wave groups hospital Japan Live virus live viruses matched controls matching measure Mild Neutralizing Neutralizing antibodies neutralizing antibody Neutralizing antibody titer Neutralizing titer neutralizing titers not decreased occurred outbreak participant Patient Quantitative assays raise Referral returned selected strain Strains the epidemic Tokyo vaccination variant variants viruses while wild-type worker
[DOI] 10.1093/cid/ciab1048 PMC 바로가기 [Article Type] Article

Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment

Article

Published on 2022-08-012022-10-05
Journal: ESMO open [Category] 진단, 치료법,

[키워드] acute respiratory syndrome anti-spike antibody antibodies baseline BNT162b2 booster booster dose booster vaccination breakthrough infections Cancer cancer patient Cancer patients Care cause CD19+ CD4+ cell counts Cellular immune response cellular immunity cellular response Chemotherapy coronavirus COVID-19 COVID-19 infection died disease dose Efficacy Endocrine evaluated excluded exclusion criteria Factor Factors high risk high-risk population hospital humoral Humoral immunity immune response Immunosuppression immunosuppressive Infection Messenger RNA Mild mRNA mRNA vaccine mRNA-1273 mRNA-based neoplasm neutralizing antibody older patients Other outcome overcome Patient positive reduced required Result severe coronavirus disease significant increase significantly increased significantly lower solid malignancy solid tumors T-cell Response treated Treatment vaccination Vaccine vaccine dose Vaccines were assessed
[DOI] 10.1016/j.esmoop.2022.100587 [Article Type] Article

Successful liver transplantation for hepatitis B-related acute liver failure in a patient with active COVID-19

활성 COVID-19 환자의 B형 간염 관련 급성 간부전에 대한 성공적인 간 이식

Case Reports

Published on 2022-08-012022-09-11
Journal: Transplant infectious disease : an official journa [Category] B형 간염, COVID19(2023년), MERS, SARS, 진단, 치료기술,

[키워드] acute COVID-19 acute liver failure Administered anti-spike antibodies anti-spike antibody Antiviral antiviral therapy benefit can not candidate competing complex coronavirus coronavirus disease COVID-19 detectable Deterioration effective Evidence evidence of female Hepatitis hepatitis B hepatotoxicity highlight hospital discharge liver liver failure Liver function liver transplant Liver transplantation management Mild monoclonal antibody nasopharyngeal omicron Patient paucity of data PCR potential risk presenting progression recipient SARS-CoV-2 secondary to significantly the patient Transplant transplantation while with COVID-19
[DOI] 10.1111/tid.13889 PMC 바로가기 [Article Type] Case Reports

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection

병원 내 SARS-CoV-2 델타 변이형 돌발성 감염에 대한 백신 접종 후 항체 평가

Observational Study

Published on 2022-07-252022-09-11
Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-S IgG Anti-spike anti-spike antibody antibody Asymptomatic B.1.617.2 BNT162b2 booster vaccination Breakthrough infection Care Casirivimab characterized collected coronavirus Course Delta variants diagnosed Diagnosis eight estimation geometric mean geometric mean titer GMT hospital Humoral immunity IgG Imdevimab Infection Inpatient LAMP Loop-mediated isothermal amplification lowest measurement Mild mild to moderate mild to moderate severity moderate monoclonal antibody mRNA vaccination nosocomial observational study outbreak public health quantified RBD protein remained respiratory retrospective risk RT-PCR SARS-CoV-2 SARS-CoV-2 delta SARS-COV-2 infection SARS-CoV-2 vaccination Sequencing serological serum sample serum samples Seven severe acute respiratory syndrome Coronavirus severity therapy Treatment uninfected vaccination variant virus viruses was done whole-genome sequencing
[DOI] 10.1371/journal.pone.0272056 PMC 바로가기 [Article Type] Observational Study

Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects

혈청 양성 환자에서 상업용 Anti-SARS-CoV-2 중화 항체 분석 평가

Article

Published on 2022-07-012022-09-11
Journal: Journal of Clinical Virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단,

[키워드] absence added addition anti-RBD Anti-RBD antibodies Anti-RBD antibody anti-spike antibody anti-Spike IgG antibody Antibody titer Area bioMérieux cells cellular receptor Commercial tests Competitive anti-RBD immunoassays correlation difficulty functional highlight house immunoassay immunoassays immunochromatographic test Interaction marker NAb titer NAb titers neutralization test Neutralizing antibodies neutralizing antibody neutralizing antibody assay New P-value patients plaque reduction neutralization PRNT qualitative test Quantitative reduction SARS-CoV-2 SARS-CoV-2 entry Sensitivity and specificity sera seropositive subject seropositive subjects Spike protein surrogate surrogate markers Surrogate markers of protection. sVNT tested the spike protein threshold thresholds titer variants of concern virus neutralization test VNT VoC
[DOI] 10.1016/j.jcv.2022.105169 PMC 바로가기 [Article Type] Article

Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron

SARS-CoV-2 오미크론의 돌발성 감염 시 항스파이크 단백질 항체 역가

Article

Published on 2022-07-012022-09-11
Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 변종, 진단,

Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohort

스위스 경찰 집단에서 COVID-19 백신 캠페인 후 혈청 감시

Article

Published on 2022-07-012022-09-11
Journal: Immunity, Inflammation and Disease [Category] 치료법,

[키워드] age anti-NCP-antibodies anti-S antibody anti-S-antibodies. anti-spike antibody antibody Antibody titer association baseline calculated Cohort Comorbidity COVID-19 COVID-19 seroprevalence COVID-19 vaccine cross-sectional demonstrated Department Follow-up visit General population had no healthcare professionals Infection infection rate male nucleocapsid protein online questionnaires participant performed reported resulting risk SARS-CoV-2 Seroconversion Seroprevalence Spike protein study participant Study participants study population These data U/mL vaccination vaccination rate vaccination rates vaccine dose was performed
[DOI] 10.1002/iid3.640 PMC 바로가기 [Article Type] Article

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization

회복기 혈장 기증자는 예방 접종 후 SARS-CoV-2의 항원 변이체에 대한 향상된 교차 반응성 중화 항체 반응을 보여줍니다

Article

Published on 2022-07-012022-09-11
Journal: Transfusion [Category] COVID19(2023년), MERS, SARS, 변종, 진단,

[키워드] Alpha anti-SARS-CoV-2 anti-spike antibody antibody Antibody neutralization antigenic antigenic variant antigenic variants antigenic variation automated Beta circulating convalescent convalescent plasma COVID-19 cross-reactive Delta determined by Donor dose Effect Elecsy focus geometric mean geometric mean titer GMT GMTs immunization infected with SARS-CoV-2 Live virus microneutralization NAb NAb titers NAbs neutralization neutralization potency neutralization test neutralize Neutralizing antibodies neutralizing antibody Neutralizing antibody response omicron Pfizer plasma Predictive prototype Quantitative reactivity reduction ROC analysis Roche Sample SARS-CoV-2 SARS-CoV-2 strain specificity strain Strains Therapeutic benefit therapy titers treat vaccination Vaccinations vaccine dose Zeneca
[DOI] 10.1111/trf.16934 PMC 바로가기 [Article Type] Article